Images

Filter by

Figure 1 Ambulatory Patient with Left Axillary Artery IABP Inserted in the Cardiac Catheterisation Laboratory Awaiting Heart Transplantation and Able to Participate in Physical Therapy
Figure 1: Ambulatory Patient with Left Axillary Artery IABP, Inserted in the Cardiac Catheterisation Laboratory, Awaiting Heart Transplantation and Able to Participate in Physical Therapy
Table 2 Summary of Randomised Controlled Trials of Patients with Heart Failure with Reduced Ejection Fraction HFrEF treated with AF Ablation
Table 2: Summary of Randomised Controlled Trials of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) treated with AF Ablation
Table 1 Summary of Observational Studies of AF Ablation in Patients with Heart Failure with Reduced Ejection Fraction HFrEF
Table 1: Summary of Observational Studies of AF Ablation in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF)
Figure 1 Ablation Lesion Set for Circumferential Pulmonary Vein Isolation
Figure 1: Ablation Lesion Set for Circumferential Pulmonary Vein Isolation
Table 2 Ongoing Large Outcome Trials of Intravenous Iron in Heart Failure
Table 2: Ongoing Large Outcome Trials of Intravenous Iron in Heart Failure
Table 1 Current Guideline Recommendations for Intravenous Iron in Heart Failure
Table 1: Current Guideline Recommendations for Intravenous Iron in Heart Failure
Figure 1 Definition and Clinical Implications of Iron Deficiency in Heart Failure
Figure 1: Definition and Clinical Implications of Iron Deficiency in Heart Failure
Figure 1 Clinical Course of LV Dysfunction in the Setting of Takotsubo Cardiomyopathy
Figure 1: Clinical Course of LV Dysfunction in the Setting of Takotsubo Cardiomyopathy
Table 2 Potential Mechanisms of Transient and Persistent Permanent Diastolic Dysfunction in Patients with Takotsubo Cardiomyopathy
Table 2: Potential Mechanisms of Transient and Persistent (Permanent) Diastolic Dysfunction in Patients with Takotsubo Cardiomyopathy
Table 1 Potential Causes of Systolic Dysfunctiona in the Setting of Takotsubo Cardiomyopathy
Table 1: Potential Causes of Systolic Dysfunctiona in the Setting of Takotsubo Cardiomyopathy
Table 2 Use of Cardiovascular Medications and Devices in Patients with HFmrEF as Reported in Recent Analyses of Data from Clinical Registries
Table 2: Use of Cardiovascular Medications and Devices in Patients with HFmrEF as Reported in Recent Analyses of Data from Clinical Registries
Table 1 Clinical Characteristics of Patients with HFmrEF HFbEF Compared to Patients with HFrEF and HFpEF
Table 1: Clinical Characteristics of Patients with HFmrEF (HFbEF) Compared to Patients with HFrEF and HFpEF